Evidence from behavioral and electrophysiological studies indicates that the induction of long term potentiation (LTP) in principal neurons of the basolateral amygdala (BLA) may underlie the acquisition of fear conditioning. Moreover, activation of dopaminergic afferents to the amygdala is thought to facilitate fear memory, and local activation of the D1 family of dopamine receptors (D1R) also enhances fear memory. The D1R family is comprised of D1 and D5 receptors, and evidence suggests that these receptors may couple through different effectors systems. Hence, D1 may preferentially couple to PKA, whereas D5 may couple through PLC. To date nothing is known about how activation of these receptors may affect the induction of LTP in the BLA. The goals of this study were to determine if D1R facilitate LTP in BLA, and if so, what signaling cascade/s is/are involved. Here we used whole cell patch clamp recording from BLA projection neurons to investigate the role D1R activation in LTP. LTP at cortical inputs to the BLA was induced with HFS using 5×100Hz/1s trains administered at 20s intervals (146±6% of baseline, n=5, 30min following LTP induction), and was blocked following NMDA receptor antagonism and intracellular calcium chelation. Significantly, induction of LTP was completely abolished in slices pretreated with the D1R antagonist, SCH23390 (10µM; 106±4% of baseline, n=6), and facilitated by inclusion of the specific dopamine (DA) uptake blocker GBR12783 in the ACSF (10µM; control: 151±3% of base line, n=5; GBR12783: 228±2% of baseline, n=6; P<0.05). Hence, release of endogenous DA is both sufficient and necessary for the induction of LTP in BLA slices. Similarly, magnitude of LTP was significantly enhanced slices treated with D1R agonist SKF38393 (50µM; control: 154 ±7% of base line, n=5; SKF38393: 182±4% of baseline, n=6; P<0.05), an effect that was blocked by pretreatment with the D1R selective antagonist SCH23390 (10µM; 161±5%, n=5). However, neither exogenous DA (50µM) nor the D2 agonist quinpirole (10µM) facilitate LTP in BLA slices (control: 157±3% of base line, n=5; DA: 161±5% of baseline, n=6). Inhibition of PKA anchoring to scaffolding proteins by intracellular application of AKAP StHt31 (1µM) 30min prior to HFS fully blocked LTP induction (100±8% of base line, n=5; 30min following LTP induction), suggesting that activation of the D1R-cAMP cascade is critical for LTP induction. Importantly, application of the membrane permeable PLC inhibitor, U73122 (10 µM), unmasked a DA facilitation of LTP (185±6% of baseline n=5). Finally, pretreatment with the membrane permeable AC inhibitor, MDL-12330A (30 µM), fully blocked SKF38393 facilitation of LTP (SKF38393: 173±5% f baseline, n=5; MDL-12330A+SKF: 143±6% of baseline, n=5; P<0.05). Together, these data suggest that the D1 and D5 receptor subtypes may play diametrically opposing roles in regulating LTP in the BLA. D1 receptor activation may enhance LTP in BLA through activating presynaptic adenylyl cyclase.
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